Analgesic Efficacy and Safety Study of T-62 in Subjects With Postherpetic Neuralgia

Phase 2 Terminated 19 enrolled Pfizer

RandomizedParallel-groupTriple-blindTreatment

The purpose of this study is to evaluate the safety and efficacy of T-62 in subjects with postherpetic neuralgia.

Outcome not reported

Stopped: “Some patients experienced asymptomatic, transient elevations in liver transaminases”

Evaluation	Drug	Modality	Dose	Route
Subject	T-62	Unknown	100 mg	—
Subject	T-62	Unknown	200 mg	—